Package 76420-229-30

{"route": ["ORAL"], "spl_id": "3aa8c7f8-ee1a-be39-e063-6294a90a0e71", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["24d8b33f-d1fb-4b4a-afbe-e2e7134dce29"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE (76420-229-10)", "package_ndc": "76420-229-10", "marketing_start_date": "20240109"}, {"sample": false, "description": "12 TABLET in 1 BOTTLE (76420-229-12)", "package_ndc": "76420-229-12", "marketing_start_date": "20250724"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-229-30)", "package_ndc": "76420-229-30", "marketing_start_date": "20220707"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-229-60)", "package_ndc": "76420-229-60", "marketing_start_date": "20220707"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-229-90)", "package_ndc": "76420-229-90", "marketing_start_date": "20220707"}], "brand_name": "Tizanidine", "product_id": "76420-229_3aa8c7f8-ee1a-be39-e063-6294a90a0e71", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "76420-229", "generic_name": "Tizanidine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20020703", "listing_expiration_date": "20261231"}